| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 29, 2025 | BSX Boston Scientific Corp | Ludwig Edward J60 | Director | Sell | 4,000 | $104.59 | $418,367.60 | -15.1% | +1.3% | - | |
| May 29, 2025 | IRIX Iridex Corp | Dizon Romeo R61 | Chief Financial Officer | Buy | 200 | $0.99 | $197.00 | +1.6% | +23.8% | -0.0% | |
| May 29, 2025 | MLSS Milestone Scientific Inc. | Bp4 S.r.l.89 | 10% Owner | Sell | 17,617 | $0.96 | $16,912.32 | - | -35.3% | -57.7% | |
| May 29, 2025 | SGHT Sight Sciences, Inc. | Encrantz Staffan74 | Director, 10% Owner | Buy | 128,189 | $3.52 | $451,734.06 | +4.0% | +20.2% | +38.1% | |
| May 28, 2025 | PEN Penumbra Inc | Elsesser Adam62 | CEO And President | Sell | 16,300 | $267.91 | $4,366,919.79 | -1.4% | +0.6% | +20.7% | |
| May 28, 2025 | ATRC Atricure, Inc. | Doraiswamy Vinayak70 | Chief Scientific Officer | Sell | 2,500 | $33.44 | $83,600.00 | -3.3% | +12.9% | -16.2% | |
| May 28, 2025 | BLFS Biolife Solutions Inc | Werner Sean60 | Chief Technology Officer | Sell | 109 | $22.46 | $2,448.14 | -0.4% | +14.8% | +13.0% | |
| May 28, 2025 | BLFS Biolife Solutions Inc | Foster Karen A.68 | Chief Quality And Operations | Sell | 251 | $22.46 | $5,637.46 | -0.1% | +14.8% | +13.0% | |
| May 28, 2025 | INFU Infusystem Holdings, Inc | Eichenbaum Kenneth D. | Director | Buy | 2,000 | $5.18 | $10,360.00 | +50.0% | +90.0% | - | |
| May 28, 2025 | BLFS Biolife Solutions Inc | Aebersold Sarah60 | Chief Human Resources Officer | Sell | 217 | $22.46 | $4,873.82 | -0.3% | +14.8% | +13.0% | |
| May 28, 2025 | IRIX Iridex Corp | Dizon Romeo R61 | Chief Financial Officer | Buy | 200 | $0.95 | $190.00 | +1.7% | +34.0% | +8.6% | |
| May 28, 2025 | BLFS Biolife Solutions Inc | Wichterman Troy60 | Chief Financial Officer | Sell | 583 | $22.46 | $13,094.18 | -0.3% | +14.8% | +13.0% | |
| May 28, 2025 | BLFS Biolife Solutions Inc | Mathew Aby J.68 | EVP &Chief Scientific Officer | Sell | 521 | $22.46 | $11,701.66 | -0.2% | +14.8% | +13.0% | |
| May 28, 2025 | BLFS Biolife Solutions Inc | Berard Todd67 | Chief Marketing Officer | Sell | 348 | $22.46 | $7,816.08 | -0.3% | +14.8% | +13.0% | |
| May 28, 2025 | ICUI Icu Medical Inc/de | Voigtlander Christian B.64 | Chief Operating Officer | Sell | 9,930 | $129.75 | $1,288,371.49 | -46.1% | -2.0% | +8.1% | |
| May 27, 2025 | MMSI Merit Medical Systems Inc | Lampropoulos Fred P66 | President And CEO | Sell | 20,000 | $96.54 | $1,930,800.00 | -1.8% | -8.6% | -35.2% | |
| May 27, 2025 | IRIX Iridex Corp | Dizon Romeo R61 | Chief Financial Officer | Buy | 100 | $1.00 | $100.00 | +0.8% | +34.7% | +7.1% | |
| May 27, 2025 | DXCM Dexcom Inc | Stern Sadie72 | EVP, Chief Hr Officer | Sell | 6,184 | $85.11 | $526,318.38 | -5.3% | -11.0% | -17.7% | |
| May 27, 2025 | AORT Artivion, Inc. | Holloway Jean F49 | SVP, General Counsel | Sell | 8,748 | $29.00 | $253,692.00 | -4.7% | +49.2% | -22.1% | |
| May 27, 2025 | TMDX Transmedics Group, Inc. | Basile Edward M64 | Director | Sell | 5,000 | $126.45 | $632,250.00 | -63.6% | -10.6% | -45.4% | |
| May 27, 2025 | COCH Envoy Medical, Inc. | Brynelsen Charles | Director | Buy | 50,000 | $1.65 | $82,402.70 | +294.1% | -28.2% | -54.6% | |
| May 23, 2025 | LAB Standard Biotools Inc. | Kim Hanjoon Alex | Chief Financial Officer | Sell | 1,428 | $0.94 | $1,343.75 | -0.2% | +30.2% | +11.8% | |
| May 23, 2025 | AORT Artivion, Inc. | Semedo Anthony B.50 | Director | Sell | 2,600 | $28.47 | $74,027.20 | -7.3% | +50.8% | -21.5% | |
| May 23, 2025 | LAB Standard Biotools Inc. | MacKay Sean | SVP &Chief Business Officer | Sell | 13,217 | $0.94 | $12,437.20 | -1.5% | +30.2% | +11.8% | |
| May 23, 2025 | LAB Standard Biotools Inc. | Egholm Michael | President &CEO | Sell | 5,473 | $0.94 | $5,150.09 | -0.2% | +30.2% | +11.8% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.